Cite
HARVARD Citation
Matsukawa, T. et al. (2016). Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation. Gut. 65 (5), pp. 777-787. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Matsukawa, T. et al. (2016). Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation. Gut. 65 (5), pp. 777-787. [Online].